TYPE 1 DIABETES: IMPACT OF SGLT-2 INHIBITORS ON GLYCEMIC CONTROL

被引：0
|
作者：
Lavrador, M. [1 ]
Araujo, B. [1 ]
Araujo, C. [1 ]
Melo, M. [1 ]
Baptista, C. [1 ]
Barros, L. [1 ]
Paiva, I. [1 ]
机构：
[1] Ctr Hosp Univ Coimbra, Endocrinol, Coimbra, Portugal
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2022年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
EP241 / #5
引用
收藏
页码：A181 / A181
页数：1
相关论文
共 50 条
  • [21] SGLT-2 inhibitors: does it matter if they prevent type 2 diabetes Comment
    Cheng, Alice Y. Y.
    LANCET DIABETES & ENDOCRINOLOGY, 2022, 10 (01): : 2 - 3
  • [22] IMPACT OF GLP-1 RECEPTOR AGONISTS AND SGLT-2 INHIBITORS ON BONE METABOLISM IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Timkina, N.
    Simanenkova, A.
    Mart'Yanova, M.
    Karonova, L.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2024, 36 : S460 - S460
  • [23] Diabetes, Antidiabetic Medications and Cancer Risk in Type 2 Diabetes: Focus on SGLT-2 Inhibitors
    Dabrowski, Mariusz
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (04) : 1 - 18
  • [24] The Impact of SGLT-2 inhibitors on laboratory parameters
    Morgovan, C.
    Moisa, D. G.
    Dobrea, C. M.
    Arseniu, A. M.
    Frum, A.
    Juncan, A. M.
    Rus, L. L.
    Chis, A. A.
    Gligor, F. G.
    Ghibu, S.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2022, 395 (SUPPL 1) : S8 - S8
  • [25] Impact of SGLT-2 inhibitors on modifiable cardiovascular risk factors in Romanian patients with type 2 diabetes mellitus
    Gherbon, Adriana
    Frandes, Mirela
    Dirpes, Darius
    Timar, Romulus
    Timar, Bogdan
    DIABETOLOGY & METABOLIC SYNDROME, 2024, 16 (01):
  • [26] Association of SGLT-2 inhibitors with bacterial urinary tract infection in type 2 diabetes
    Tanriverdi, Mustafa
    Bastemir, Mehmet
    Demirbakan, Hadiye
    Unalan, Alperen
    Turkmen, Merve
    Tanriverdi, Gulsen Ozkan
    BMC ENDOCRINE DISORDERS, 2023, 23 (01)
  • [27] Expect the Unexpected: SGLT-2 Inhibitors in the Treatment of Type 2 Diabetes and/or Heart Failure
    Seferovic, Jelena P.
    Seferovic, Petar M.
    CARDIOLOGY, 2020, 145 (05) : 321 - 323
  • [28] Association of SGLT-2 inhibitors with bacterial urinary tract infection in type 2 diabetes
    Mustafa Tanrıverdi
    Mehmet Baştemir
    Hadiye Demirbakan
    Alperen Ünalan
    Merve Türkmen
    Gülşen Özkan Tanrıverdi
    BMC Endocrine Disorders, 23
  • [29] In type 2 diabetes, SGLT-2 inhibitors reduce risk for major kidney outcomes
    Ng, Sarah Yoon Ai
    Zhu, Doreen
    Herrington, William G.
    ANNALS OF INTERNAL MEDICINE, 2020, 172 (04) : JC18 - JC18
  • [30] SGLT-2 Inhibitors and Circulating Progenitor Cells in Diabetes
    Fadini, Gian Paolo
    CELL METABOLISM, 2020, 31 (05) : 883 - 883
12345